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ABSTRACT:  
Charge is the fundamental property that enables polyamines to interact through 
reversible ionic interactions with many different biomolecules. Modifications in 
the structure of polyamine analogues can alter their conformation without 
causing any changes in the acidity of the amino groups in the polyamine 
backbone. This thesis focuses on analogues that have reduced basicity of their 
amino groups and therefore are not fully protonated at physiological pH.  
The aim of this study was to conduct a systematic biological characterization of 
the newest isosteric charge deficient analogue of Spm, 1,12-diamino-3,6,9-
triazadodecane (SpmTrien), which is capable of chelating Cu2+. In addition, the 
corresponding Spd analogue, 1,8-diamino-3,6-diazaoctane (Trien), was 
systematically characterized for its effects in polyamine metabolic route. 
Furthermore, the protonation and pKa values of SpmTrien were determined in 
order to gain a deeper understanding of the biochemical features of this 
molecule. 
The determined pKa values of SpmTrien (3.3, 6.3, 8.5, 9.5 and 10.3) are extremely 
low for amino groups and the net charge of the molecule is three (+3) at pH 7.4. 
Thus this novel compound is a functional chemical tool with which to study the 
role of charged amines in the regulation of polyamine-dependent biological 
processes. Both Trien and SpmTrien displayed polyamine like properties to 
some extent. With respect to their biological properties, Trien and SpmTrien 
were found to be substrates of the polyamine acetylating enzyme 
spermidine/spermine N1-acetyltransferace (SSAT). Altough Trien or its 
acetylated metabolites were not substrates of either spermine oxidaze (SMO) or 
N1-acetyl polyamine oxidase (APAO), N12-Ac-SpmTrien was a good substrate of 
APAO resulting Trien as the oxidation product. Furthermore, the concentration 
of SpmTrien was found to be as high inside cells as the concentration of natural 
polyamines even though the molecule did not compete efficiently for 
transportation inside DU145 cells, suggesting that some other mechanism is 
available for the entry of the molecule into the cells. Trien has already been used 
in various different studies, ranging from Cu2+ chelation to cancer treatment, 
thus proving its potential. Since SpmTrien is a bioactive precursor of Trien, it 
should also have great potential as a chemical research tool; this study provides 
a firm foundation for future research.  
National Library of Medical Classification: QU 61; QU 120 
Medical Subject Headings: Polyamines; Biogenic Polyamines/metabolism; Spermine/analogs & 
derivatives*; Magnetic Resonance Spectroscopy; Mass Spectrometry; Cell Proliferation/drug 
effects; Spermine/chemistry 
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1 Introduction 
Naturally occurring polyamines spermidine (1,8-diamino-4-azaoctane, Spd) and Spermine 
(1,12-diamino-4,9-diazadodecane, Spm) and their diamine precursor putrescine (1,4-
diaminobutane, Put) are an absolute requirement for mammalian cell growth. Their 
concentrations can reach millimolar levels in rapidly proliferating cells and changes in the 
homeostasis of the natural polyamines are often linked to various pathological conditions, 
such as acute pancreatitis, diabetes and cancer.1, 2 The positive charge of the natural 
polyamines and their analogues at physiological pH is their most important feature, 
ensuring their molecular recognition by different cellular constituents and subsequently 
enabling the regulation of important cellular functions, such as proliferation, differentiation 
and functioning of different ion channels. Individual polyamines have been shown to 
interact in a specific manner with DNA and also with different proteins. This property 
separates the polyamines from all other positively charged cations found inside cells.3, 4  
Various different families of polyamine analogues have been synthesized not only for 
research purposes but also for potential therapeutic use, but only a very small number of 
these families have the total charge decreased at physiological pH as compared to their 
natural counterparts. Analogues that contain amino groups that are not protonated at 
physiological pH will be called charge-deficient in this thesis. The only charge-deficient 
families of analogues that have been systematically biochemically characterized before the 
beginning of this work were the difluorinated-5, 6 and aminooxy7-10 analogues of Put, Spd 
and Spm. In addition, the protonation of difluorospermines and –spermidines has been 
examined in detail with NMR to differentiate the amounts of all microscopic populations of 
different charges of the molecules.11  
Even though the polyamines have been used in plethora of different studies for over forty 
years now, their biochemistry still has not been fully resolved. Recently, a novel mechanism 
for the regulation of antizyme (AZ) has been proposed through ionic binding of Spm and 
Spd.12 Alternatively charged polyamine analogues could be used in interaction studies to 
illustrate the importance of the localization of the charge. The main goal of this work was to 
conduct a comprehensive chemical and biochemical characterization of the novel family of 
spermine analogues. One of its subsequent aims which was needed to achieve the 
satisfactory characterization of these analogues was to develop an 1H-15N 2D NMR method 
to allow the determination of protonation of polyamine analogue, 1,12-diamino-3,6,9-
triazadodecane (SpmTrien), which has largely overlapping signals in both 1H and 13C 
spectra.(Paper I) 
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2 Review of the literature 
2.1 POLYAMINES 
2.1.1 A brief introduction to the polyamines 
Polyamines are a class of compounds that contain many amino groups, which are 
connected to each other via a hydrophobic carbon chain. In general, polyamines can be 
either linear or branched but biochemically the term polyamines is used to denote the 
naturally occurring polyamines, Spd and Spm and their diamine precursor Put (hereafter 
all will be considered as natural polyamines), that are linear positively charged molecules 
at physiological pH (figure 1).  
 
Figure 1. The chemical structures and the pKa values13 of the naturally occurring polyamines. 
The natural polyamines can be found in all eukaryotic cells and the concentrations of 
polyamines within cells can reach mM levels. Most of the polyamines are bound to various 
different cellular constituents. This is due to one key feature of these molecules, i.e. their the 
positive charge, that enables them to interact with negatively charged components of the 
cell such as DNA, RNA, anionic proteins and phospholipids.3,14,15 However, it is not simply 
the charge but rather the correct distribution of the charge(s) along the polyamine backbone 
that give the unique features of polyamines and this differentiates them from other 
important cations such as Mg2+  or Zn2+ cations.4  The charge enables Spd and Spm to link 
the major and minor grooves of DNA both inter— or intramolecularly, with a preference 
for interacting with the single DNA strand.3, 16 The stability of the polyamine-DNA-
complexes follows the number of positive charges, as the complexes made with Spm are the 
most stable and those with Put being the least stable. Moreover, norspermine (1,11-
diamino-4,8-diazaundecane, 3-3-3)  and the N1,N11-diethylnorspermine (1,11-
bis(ethylamino)-4,8-diazaundecane, BE-3-3-3) were reported to have a much lower binding 
affinity for DNA as well as a different binding site when compared to the natural 
polyamines.17  Polyamine-tRNA interaction studies have revealed that the preferred 
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binding sites of Spd, Spm and Put differ slightly from their complexes with DNA and at 
low concentrations, both Spd and Spm bind more effectively to tRNA than DNA.18 In 
addition, the polyamine-protein interactions show charge dependency. For example, when 
the interactions of Spd, Spm and diethyl analogues, BE-3-3-3 and 1,15-(ethylamino)4,8,12-
triazapentadecane (BE-3-3-3-3) with bovine serum albumin (BSA) were studied, the 
stability of the BSA-Spm complex was found to be higher than that of the BSA-Spd 
complex, and likewise, the BSA-BE-3-3-3-3 complex was more stable than BSA-BE-3-3-3.19  
Furthermore, the BSA complexes of Spd and Spm were found to be more stable than the 
complexes with the diethylated analogues. Recent results have indicated that polyamines 
can also modulate protein-protein interactions and therefore control the functions of 
proteins.14 Specific binding sites for the polyamines in the CYP11A1 electron transfer 
system were found. These could modulate interactions between protein components and 
thus affect the biosynthesis of steroid hormones. Positively charged polyamines can also 
modulate ion-channel functions.20 
The homeostasis of natural polyamines is strictly regulated and the changes in their 
concentration are linked to various different diseases.1, 2 There are high concentrations of 
polyamines in rapidly proliferating cells and polyamine metabolism has been a target of 
cancer chemotherapy and the development of inhibitors of polyamine metabolism has been 
of keen interest to many different research groups.21 It is also good to remember that not 
only a high concentration of polyamines but also a low level can create pathological 
conditions. Acute pancreatitis was found to be cured with polyamine analogues that could 
fulfill the tasks of the lacking natural polyamines.22  
The facts that the polyamines are bound to various different macromolecules within cells 
through reversible ionic interactions and the changes in their homeostasis create 
pathological states to cells give the base for this work as the modulation of charge can 
create new and important knowledge about the interactions of different macromolecules 
with polyamines and their analogues. 
2.1.2 Metabolism of natural polyamines  
The natural polyamines Put, Spd and Spm are synthesized from the amino acids ornithine 
and methionine.3, 23 The biosynthesis of the molecules as well as the catabolism is tightly 
regulated and there is also an active transport system for polyamines (figure 2). 
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Ornithine decarboxylase (ODC, EC 4.1.1.17) is the first rate limiting enzyme of polyamine 
metabolism, producing Put by decarboxylating the amino acid, ornithine (Orn). S-
adenosylmethionine is transformed by S-adenosylmethionine decarboxylase (AdoMetDC, 
EC 4.1.1.50) into decarboxylated S-adenosylmethionine (dcSAM), which is used as a 
substrate for the aminopropyltransferases, spermidine synthase (SpdSy, EC 2.5.1.16) and 
spermine synthase (SpmSy, EC 2.5.1.22), which are constitutively expressed and active as 
homodimers. Both ODC and AdoMetDC have very short half-lives that change during the 
cell cycle.25 The aminopropyltransferases catalyze the synthesis of Spd from Put and 
subsequently Spm from Spd. Both Spd and Spm are N1-acetylated by the highly inducible 
polyamine catabolizing enzyme spermidine/spermine N1-acetyltransferase (SSAT, EC 
2.3.1.57).26-28 SSAT has a short half-life and it utilizes acetyl coenzyme A for the acetylation 
reaction. The acetylation of the polyamines Spd and Spm converts the molecules into 
substrates of constitutively expressed N1-acetyl polyamine oxidase (APAO, EC 1.5.3.13), 
which catabolizes acetylated Spm to Spd and acetylated Spd to Put29, 30. The acetylated 
forms of Spd and —Spm can also be exported from the cell. The most recently discovered 
polyamine catabolizing enzyme is spermine oxidase (SMO, EC 1.5.3.16), which uses Spm as 
a substrate producing Spd, 3-aminopropanal and H2O2.31-33 Furthermore, SMO is inducible 
and a major source of reactive oxygen species in various pathogenic states.1, 34 Even though 
the biosynthesis of the polyamines is tightly regulated, the active polyamine transport can 
also regulate the polyamine concentration and it is often upregulated in pathological states 
in the cell.35 The polyamine transport system has been characterized in E. Coli and yeast (for 
review see36), but the eukaryotic polyamine transport system is complicated. Recently, some 
convincing data has been published36-38 that has facilitated the creation of models for the 
mammalian polyamine uptake system24. The polyamine transporter is regulated by a small 
short living protein, antizyme, which controls the transport by feedback-inhibition. 
Antizyme has high affinity for ODC and the binding leads to the dissociation of the ODC 
dimer into monomers and ultimately to the proteosomal degradation of ODC.39 
The polyamines can also be terminally deaminated by other enzymes that are not involved 
in the polyamine catabolizing route.40, 41 For example, deamination can be achieved by 
many different enzymes such as monoamine oxidase, diamine oxidase and serum amine 
oxidase. 
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2.2 OVERVIEW ON THE ACIDITY 
Proton transfers are common phenomena in both chemistry and biochemistry and ionic 
interactions are crucial in the molecular recognition of different biomolecules. Since acids 
and bases can exist in a veriety of structures a fundamental knowledge about acidity (and 
basicity) is important. It is also useful to appreciate what factors affect the acidity of 
compounds. The simplest examples of an acid or a base are the easily recognizable 
functional groups. Often the acidity or basicity of a compound correlates with its reactivity 
and almost all sorts of reactions can be explained as acid-base reactions. For example, when 
acetic acid is added to water it undergoes a reaction forming a negatively charged ion while 
protonating water (scheme 1). This phenomenon is called the dissociation of acetic acid. 
 
Scheme 1. The dissociation of acetic acid in water 
The thermodynamics of this reaction can be expressed as a Ka value, which can be used to 
compare the acidity to water (Equation 1). 
Eq 1.    
The Ka values can vary extensively between strong acids and bases and therefore the acidity 
scale, which is called pKa, the negative logarithm of Ka, is used to compare the strengths of 
acids. Since the pH affects the concentration of H3O+ molecules in solution, thus altering 
also Ka and pKa values, the protonation of acetic acid can be examined with the Henderson-
Hasselbalch equation (equation 2) 
Eq 2.   
As mentioned above, different functional groups have different pKa values based on their 
acidities and some representative examples are given in figure 3. In general, the pKa value 
indicates the bond strength and/or ability to stabilize the formed charge in the X—H 
system; a weak bond has a low pKa value and a strong bond has a high pKa value.   
 
Figure 3. The pKa values of various different molecules 
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The pKa values of the above compounds are explained mainly due to their different 
electronegativities, e.g. the CF3 group is more electronegative than CH3, or due to resonance 
properties, e.g. CH3CO2- has two resonance structures but RO- has only one. 
The elecronegativity affects the acidity in two ways, the first via the electronegativity of the 
atom, which the proton is directly attached and the other way is caused by electron 
withdrawing groups near the acidic site of the molecule. This phenomenon is called an 
inductive effect and one of many examples is the change in acidity caused by a neighboring 
electronegative group. The electronegativity of atoms follows the number of protons in the 
nucleus; this can be seen in the periodic table where the electronegativity increases when 
one moves from left to right and from bottom to top. Other internal factors that affect the 
acidity of compounds are electrostatic effects, hybridization, aromaticity and solvation 
The external factors such as exchange of the solvent from H2O to DMSO can cause dramatic 
changes in the pKa values of molecules. The pKa value can vary considerably if the molecule 
binds to an active site of an enzyme, which corresponds to a completely different 
environment as compared to a solution. The differences in the pKa values of free amino acid 
residues solely or in a protein backbone might even explain some of the differences in the 
specificities of the interactions encountered with cationic polyamines.  
2.2.1 Macroscopic and microscopic pKa values of polyprotic acids or bases 
As mentioned above, the pKa value describes the particular pH value in which half of the 
population of an acid or a base is in an ionic form. With molecules that contain only one 
acidic or basic group, the pKa value also describes how the charge is localized in the 
molecule while the pH changes. This is not the case with polyamines, as their name already 
reveals, because there are more functional groups that can be ionized and all of these 
groups have their own distinct pKa values. The macroscopic pKa values of these molecules 
contain only the information about the populations of different charge states in each pH but 
not how the charge is localized in the structure. These charge populations can be calculated 
using the Henderson-Hasselbalch equation42, 43, which gives a good approximation of the 
net charge of a molecule at the calculated pH. The localization of the charge is important for 
the recognition of the polyamines therefore providing more accurate information about the 
interactions of cationic polyamines. The constants that describe the protonation of the 
individual amino groups are called microscopic pKa values and they also contain the 
information needed to assign the localization of the charge into the polyamine backbone.44, 
45 For example, Spd has three pKa values but the charge of mono- and diprotonated states 
can be represented in three different isomers and 12 microscopic pKa values are needed to 
describe the protonation of Spd in detail (scheme 2).  
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Scheme 2. A) Macroscopic protonation Spd. L represents Spd and H the charge; B) Microscopic protonation of Spd. Each arrow 
represents a distinct microscopic pKa value. 
The three most common methods used to determine pKa values of molecules are titrations 
using potentiometry, spectrophotometry and NMR with potentiometric titration being the 
most often used in the pKa determination of polyamines. In contrast, the 
spectrophotometric method cannot be used because polyamines lack chromophores in their 
structure.46 The potentiometric titration is an automated method and it can be uset to 
determine the macroscopic pKa values of the polyamines from a small amount of sample. 
The other option is the NMR-pH titrations that allow the estimations of both macro- and 
microscopic pKa values.44, 45, 47 The NMR measurements can also be used to extract structural 
data about the molecule. The selection of the strategy for the calculation of microscopic pKa 
values of polyamines and their analogues depend on the amount of amino groups, the pKa 
values, and the general structure of polyamine. It is known that all of the microscopic pKa 
values of polyamines, or any polyprotic acid, with more than three non-identical ionizable 
groups cannot be determined without making special assumptions or having additional 
information.48 Thus, cluster expansion methods need to be used for the molecules that do 
not conform to the above criteria. With these computational methods, the microconstants 
can be calculated from even complex molecules, with many ionizable groups, using only 
macroscopic pKa values.49  
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2.2.2 Short overview to the NMR methods used for the pKa determination of polyamines 
and their analogues  
NMR-pH titrations are commonly used for the determination of the acid dissociation 
constants of polyamines (figure 4). The method provides molecular insights into the 
protonation thus providing detailed information about the microspecies at different pH 
values. The main disadvantage of the method is the higher amount of the compound 
needed as compared to the traditional potentiometric titration, even though the compound 
of interest can be retained from the sample(s) in either basic or salt form. D2O is used as a 
solvent for the most of the NMR—pH titrations to avoid an excess H2O peak. A correction 
has to be added to the pD values in order to obtain pH values.50, 51 NMR-pH titrations can 
also be done from impure mixtures if the compounds in the mixture do not affect each 
other´s protonation as well as in various different solvent systems including biological 
fluids. 
 
 
Figure 4. An example of 1H-NMR-pH titrations; pH vs. chemical shift of aminooxy neighboring CH2-group of 1-aminooxy-3-
aminopropane (APA) around the pKa of the aminooxy group (4.2).52  
The pKa values and protonation of metal chelating polyamines with ethylenic chain 
between amino groups were studied using 1H NMR-pH titrations already in 1964.53 The 
macroscopic pKa values and the protonation of Spd have been determined with 13C—54 and 
15N NMR55 methods with comparable accuracy to those obtained with the potentiometric 
titration. Furthermore, the 15N NMR method displayed advantages over the 1H— and 13C 
NMR methods since it had higher sensitivity and more straightforward spectral analysis.  
However, the low abundance of 15N (0.368 %) makes the method less favorable. Later, a 
1H—13C coupled 2D NMR method was used to determine the protonation and macroscopic 
pKa values of spermine.44 1H— and 13C NMR data was combined for simultaneous analysis 
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giving the most precise results and 2D NMR was shown to be superior in the determination 
of overlapping 1H signals of Spm. The 13C NMR method has also been used for the 
detection of pKa values of polyamine-containing wasp toxins with 1H-13C NMR being used 
to obtain 1H NMR shifts.56 In this case, the proton chemical shifts of Spm part of PhTX-343 
did not change sufficiently during ionization to allow non-linear analysis illustrating the 
superiority of the use of 13C NMR chemical shifts for the detection of protonation. 13C NMR 
chemical shifts were used also for the determination of protonation constants of fluorinated 
polyamine analogues.11 Recently, the 1H-15N NMR method with indirect detection of 15N 
NMR shifts was applied to obtain the protonation map of the next generation charge 
deficient Spm analogue (figure 5) (Paper I). This method was chosen to overcome the 
spectral analysis problems caused by the highly overlapping 1H and 13C data.  
  
Figure 5. Overlay of 1H-15N correlated 2D NMR spectra in pH range 2 to 11 (From left to right) of 1,12-diamino-3,6,9-triazadodecane 
(SpmTrien). Each of the five nitrogens is represented with a different color.57 
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2.3 INTRODUCTION TO CHARGE DEFICIENT POLYAMINE ANALOGUES 
Only a few different rational methods have been used to reduce the basicity of the amino 
groups in the polyamine backbone and thus to decrease the net charge of polyamine 
analogues. The ideal way to alter the basicity of any polyamine analogue would be one that 
causes as little steric disturbance as possible so that the analogue would still resemble the 
natural polyamines as much as possible. Currently, there are a few different ways available 
to reduce the basicity of the amino groups in the polyamine backbone. The four most 
widely used methods are: 1) the introduction of one or two fluorines in the polyamine 
backbone; 2) exchange of NH2CH2- for NH2O-; 3) reduction of the length of carbon chain to 
two between the amino groups; 4) the use of conformationally restrained cyclic amines 
instead of an aliphatic chain. In addition to these classes of analogues, also compounds that 
have their secondary amino groups exchanged to ether or thioether functionality have been 
synthesized but an analysis of their properties has been intentionally omitted from this 
thesis. Charge deficient polyamine analogues represent valuable tools for biochemists 
trying to elucidate the importance of the charge in polyamine recognition and binding.  
2.4 FLUORINATED ANALOGUES OF THE NATURAL POLYAMINES  
The substitution of hydrogen atoms to the most electronegative element fluorine (Pauling 
electronegativity 4) in the polyamine backbone was one of the first strategies used to 
influence the pKa values of neighbouring amino groups (table 1). Fluorine is the smallest 
feasible element which can replace hydrogen, even though its size is nearly isosteric to O, 
but often the C—H bond can be replaced with C—F bond with minimal steric 
disturbances.58 On the other hand, the C—F bond can mimic C=O bond since it has the 
same kind of charge distribution. Moreover, fluorine forms hydrogen bonds, where it acts 
as an acceptor, similarly to C=O group. The NMR sensitivity of the naturally occurring 
stable isotope 19F is comparable to the sensitivity of 1H in NMR studies providing the 
opportunity to use 19F NMR spectroscopy for the monitoring of the fluorinated compounds 
in vitro and in vivo, while the radioactive isotope of fluorine (18F) can be used for positron 
emission topography (PET) experiments. Fluorinated putrescine analogues have been used 
in both PET and NMR experiments in vivo. 59, 60 
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Table 1. The structures and the pKa values of the fluorinated polyamine analogues. 
Abbr. Compound 
pKa Net 
Charge Ref. 1 2 3 4 
Put 
 
10.72 9.44   1.99 13 
2-F-Put 
 
9.75 8.15   1.84 6 
2,2-F2-
Put 
 
9.45 6.80   1.19 6 
2,2-3,3-
F4-Put 
 
6.2 4.6   0.06 61 
Spm 
 
10.98 10.09 8.83 7.94 3.74 11 
6-F-
Spm 
 
10.7 9.7 8.04 6.62 2.95 11 
6,6-F2-
Spm 
 
10.7 9.8 7.74 5.11 2.69 11 
Spd 
 
10.49 9.81 8.34  2.89 11 
6-F-Spd 
 
10.49* 
10.40# 
9.0* 
9.55# 
6.91*  
7.18# 
 2.22* 
2.37# 
11* 
5# 
6,6-F2-
Spd 
 
10.2* 
10.34# 
9.76* 
9.29# 
5.16* 
5.70# 
 2.00* 
2.01# 
11* 
5# 
7-F-Spd 
 
10.28 9.00 7.80  2.69 5 
7,7-F2-
Spd 
 
10.25 8.24 6.64  2.02 5 
2,2-F2-
Spd 
 
10.30 7.30 5.50  1.45 5 
DESpm 
 
11.20 10.77 9.42 8.25 3.87 62 
FDESpm 
 
10.48 9.41 4.81 4.09 1.99 62 
The pKa values were determined with *NMR— or #potentiometric titration. The net charge at pH 7.4 has been calculated from the 
published pKa values using the Henderson-Hasselbach equation. 
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2.4.1 Chemistry of the fluorinated polyamine analogues 
The first fluorinated polyamine analogues were synthesized over 20 years ago when the 
synthesis of the radioactive 2-18F-putrescine was described60. In addition, non radioactive 2-
fluoroputrescine (2-F-Put) and 2,2-3,3-tetrafuoroputrescine (2,2,3,3-F4-Put) were synthesized 
at the same time63 (scheme 3). The introduction of one fluorine into the 2-position of the 
putrescine backbone slightly lowered the net charge at pH 7.4 but it still remained mostly 
doubly positively charged, while the net charge of 2,2- difluoroputrescine (2,2-F2-Put) was 
predominantly +1 and both of the amino groups in 2,2-3,3-F4-Put were in the base form 
(table 1). 
 
 
a) DAST, CH2Cl2, -78ºC; b) PhtNK, DMF; c) Conc HCl 
Scheme 3. The synthetic routes to 2-F-Put and 2,2,3,3-F4-Put. 
The syntheses of 2,2-F2-Put and the higher spermidine and spermine derivates have been 
carried out starting from 2,2-difluoro-1,4-butanediol but the only available references to 
these compounds are in patents64, 65, and though the authors have claimed that they intend 
to publish these syntheses in the peer reviewed scientific literature, they are still not 
available in the published literature (scheme 4).  
 
Scheme 4. The synthesis of the gem-difluoro-polyamines. 
While the 2-F-Put still resembles Put at physiological pH, the effect of the attachment of a 
single fluorine into the polyamine backbone of Spd or Spm causes a more extensive 
decrease in the net charge of the molecules and the net charge of the gem-difluoro-
analogues of Spd and Spm is drastically lower as compared to the parent polyamines (table 
1). The pKa values of 6-fluoro-spermidine (6-F-Spd) and 6,6- difluoro-spermidine (6,6-F2-
Spd) reported by  Frassineti et al.11 determined by 13C-NMR differ from those reported by 
  
29 
 
Baillon et al.5 who used potentiometric titration. Interestingly, there is no major difference 
in the net charge, calculated at pH 7.4 for the published pKa values of both methods, of 6-F-
Spd but the pKa value of the primary amine of aminobutyl end reveals a 0.55 unit difference 
between the methods. Similarly the estimation of the net charge of 6,6-F2-Spd is nearly 
identical with both methods but the pKa of the primary amine of the aminobutyl end shows 
a marked increase as determined with the NMR method in comparison to the pKa value 
determined with potentiometric titration. All of the mono fluorinated analogues discussed 
later are racemic mixtures of both enantiomers and one must keep in mind the fact that at 
least the enantiomers of the α-methylated analogues of Spd and Spm have different 
biochemical properties.66 
2.4.2 Analogues in the polyamine metabolizing pathway. 
Both 2-F-Put and 2,2-F2-Put are substrates of SpdSy and metabolized into 6-F-Spd and 6,6-
F2-Spd, respectively67, but neither 7-fluoro-spermidine (7-F-Spd) nor 7,7- difluoro-
spermidine (7,7-F2-Spd) were detected6, 67. Furthermore, the accumulation of 2-F-Put was 
twice as high as the accumulation of 2,2-F2-Put in tumors and even higher in normal cells, 
which is not surprising, as 2-F-Put possesses almost the same net charge as Put. The affinity 
of 2-F-Put is high (Km 12 μM) for SpdSy and 2,2-F2-Put has a similar affinity to the natural 
substrate Put, but it showed mixed type inhibition at concentrations above 25 μM. The 
mono- and difluorospermidines, except for 2,2-difluorospermidine (2,2-F2-Spd),  were 
found to be substrates of SpmSywith different substrate capabilities.5 This was one of the 
first pieces of evidence for the role of charge in polyamine biochemistry. The affinity of 6-F-
Spd is identical to that of Spd for SpmSy and 6,6-F2-Spd have almost as good affinity 
whereas the affinity of 7-F-Spd is elevated eight fold and that of 7,7,-F2-Spd is increased by 
over 100 fold. Interestingly, 7-F-Spd and 7,7-F2-Spd show substrate inhibition of the 
enzymes with reversed Ki values compared to the Km values; 7-F-Spd had much higher Ki 
than 7,7-F2-Spd.   
While both 2-F-Put and 2,2-F2-Put were able to substitute for Put in the biosynthetic 
pathway, 2-F-Put did not support cell growth68, even though there are also reports that 2,2-
F2-Put on the other hand did seem to be able to support normal, but slightly retarded, 
growth of chick embryos after administration of α-difluoromethyl ornithine (DFMO)67. Put 
is a known activator of eukaryotic SAM-decarboxylase and the modulation of the charge in 
both 2-F-Put and 2,2-F2-Put decreased the affinity of the enzyme for these analogues.69 
The fact that 2-F-Put behaves nearly identically to Put in vitro and in vivo, even though it is 
dehalogenated by diamine oxidase60, made the following polyamine metabolic flux possible 
using the ornithine analogue 4-fluoro-ornithine, which is metabolized by ODC to 2-F-Put.68, 
70 These studies also confirmed that 6-F-Spd and 6-F-Spm were substrates of SSAT.  While 
there are also some findings indicating that 6,6-F2-Spd may also be a substrate of SSAT no 
convincing data has been presented for this speculation.71 The gem-difluoro spermidines 
were tested to examine if they were substrates of hepatic acetyltransferase activity. In 
experiments conducted with the desalted supernatant fraction of rat liver it was observed 
that both 7,7-F2-Spd and 2,2-F2-Spd were 1.8 times better substrates than Spd; 6,6-F2-Spd 
also showed good substrate properties (1.4 times better).7 It is worth noting that the 
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acetylating enzyme of the hepatic fraction is unknown and Vmax for each of the acetylation 
was under 100 pmol/min /mg soluble liver protein. Furthermore, 7,7-F2-Spd was converted 
to two acetylated metabolites, whereas only one metabolite was observed with the other 
two analogues 
2.4.3 Analogues and post-translational modifications 
Due to the decrease in the pKa values of 6,6-difluorospermine (6,6-F2-Spm) the affinity of the 
analogue for calf thymus DNA was greatly reduced when compared to Spm.72 6-F-Spd and 
6,6-F2-Spd were shown to be inhibitors of deoxyhypusine synthase (IC50 48μM and 14 μM 
respectively) whereas 7,7-F2-Spd caused no inhibition suggesting that both of the primary 
amines need to be protonated to permit the recognition by the enzyme.73  Deoxyhypusine 
synthase catalyzes also a reverse reaction where the end product is homospermidine 6-F-
Spd, 6,6-F2-Spd nor 7,7-F2-Spd were not donors of the diaminobutyl chain to the main 
product deoxyhypusine or homospermidine.74 Different substrate profiles were also 
observed for gem-difluorospermidines with glutathionylspermidine synthetase of E.coli 
where 2,2-F2-Spd was found to be a superior substrate of the enzyme when compared to the 
natural substrate Spd or other fluorinated Spd analogues.75 These findings provided some 
mechanistic insights into the way that this enzyme functions e.g. substrate preferences.   
2.4.4 Fluorinated analogues of N,N-di-ethyl-spermine 
The charge deficient analogue of N1,N12-diethylspermine (1,12-bis(ethylamino)-4,9-
diazaundecane, BESpm) N1,N12-ditrifluoroethyl-spermine (1,12-bis(trifluoroethylamino)-4,9-
diazaundecane, FBESpm) was synthesized to allow investigation of the role of charge in the 
polyamine transport system. This analogue competed only weakly with Spd for uptake and 
did not have any growth retarding features of BESpm in L1210 cells.76 Furthermore, BESpm 
and FBESpm can be considered as being nearly identical, although with different total 
charges at pH 7.4, because their Nα-Nα´ and Nα-Nβ distances are reported to be nearly 
identical. However FBESpm could not modulate NMDA receptor activity nor did it exert 
any effect on the polyamine biosynthetic enzymes and polyamine pools.62, 76  Another 
fluorinated analogue of BESpm N1-N12-diethyl-6,6-gem-difluoro-spermine has been 
synthesized starting from 1,3-propanediol using the Mitsunobu reaction with low yields 
but its chemical and biochemical properties have not been clarified.77 
2.4.5 Fluorine containing charge deficient ornithine analogues. 
DFMO (figure 6) is one of the most widely used inhibitors of polyamine metabolism in 
studies of polyamine biochemistry. It is a rationally designed suicide inhibitor of pyridoxal-
5′-phosphate (PLP) dependent ODC. The introduction of the difluoromethyl group into the 
α-position of ornithine caused a reduction in the pKa values of the molecule, but the 
reduction was not responsible for the inhibitory effect of the molecule. The ability of DFMO 
to inhibit ODC activity is believed to be based on F- to function as a leaving group58 and the 
mechanism by which DMFO inhibits ODC is now well characterized78. DFMO is used as a 
racemic mixture of both D- and L-enantiomers and both of the enantiomers form the 
covalent enzyme-inhibitor complex with ODC, latter posesses 20-times higher affinity for 
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the enzyme.79 Interestingly, absorption of DFMO showed enantioselectivity in the rat with 
the L-form being less well absorbed.80  
 
Figure 6. The structure and the pKa values of DFMO and Orn 
The decrease in the pKa value of the α-amino group of DFMO as compared to Orn did not 
affect the molecular recognition by ODC but the molecule posessed other rather interesting 
chemical features. When DFMO was reacted with di-tert-butyl dicarbonate, only the mono 
Boc- derivate of DFMO was formed, thus indicating that the alpha-amino-group of the 
analogue was nonreactive.81 Furthermore, the monoprotected DFMO was used in peptide 
coupling reaction and did not form any polymers. This is rather surprising as other α-
difluoro amino acids have been successfully incorporated into the middle of the peptide 
chain and also into the C-terminal.82 Furthermore, the steric effect of α-difluoromethyl 
phenylalanine should be at least as strong as those found in DFMO. This highlights the 
possibility that there might be alternative explanations for the non-reactivity of DFMO 
other than simply the steric effect.  
Other fluorinated analogues of Orn have also been synthesized with higher inhibitory 
potencies than DFMO, e.g. α-fluoromethyl ornithine and its methyl- and ethyl esters83 and 
α-fluoromethyl-dehydroornithine and its ethyl ester84, 85.   
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2.5 AMINOOXYANALOGUES OF NATURAL POLYAMINES 
Another family of charge deficient analogues of natural polyamines was introduced in the 
middle of the 1980s when a charge deficient isosteric analogue of putrescine, 1-aminooxy-3-
aminopropane (APA), was used to inhibit ODC.9 The introduction of the aminooxy or —
oxa group into the polyamine backbone caused a minimal steric disturbance compared to 
the original NH2CH2 moiety making the family of analogues very similar in their spatial 
characteristics to the corresponding polyamines. The pKa value of aminooxy group is 
around five, which is roughly five orders of magnitude lower compared to the amino 
group, therefore meaning that these molecules are charge deficient at physiological pH. 
This causes a drop of one unit in the total net charge of the analogues at physiological pH 
when compared to their parent polyamines. The main disadvantage of the exchange of 
amino groups to their aminooxy equivalents in the analogues of Put and Spd is their high 
reactivity with carbonyl containing molecules, this can also be considered as an advantage, 
the aminooxy containing molecules are suitable for use in click chemistry86. 
2.5.1 Chemistry of the aminooxy and –oxa analogues  
There are few feasible synthetic routes for the preparation of APA and the other aminooxy 
analogues of natural polyamines.87-90 All of the synthetic strategies rely on the use of N-
protected hydroxylamines, which react readily with electrophiles i.e. for the synthesis of 
APA, ethyl N-hydroxyacetimidate, a good starting material for any of these molecules, was 
first reacted with 1-bromo-3-chloropropane and the reaction intermediate was then 
converted into APA (scheme 5).87 For the synthesis of 3H-labeled APA 3-
aminoxypropionitrile was reduced with catalytic tritylation into the tritylated product.91 In 
addition, the backbone modified analogues of APA have been synthesized with a similar 
methodology.90 The charge of APA and other aminooxy analogues of Put is one (+1) in 
physiological pH because of the low pKa value of the aminooxy group. 
 
 
Scheme 5. One of the synthetic routes for the synthesis of APA87 
The synthesis of Spd analogues started from a protected aminooxy precursor (ethyl N-
hydroxyacetimidate), which was first converted to a suitable synthon and then extended 
with diamine to 1-aminooxy-3-N-(3-aminopropyl)-aminopropane (AP-APA) or N-(2-
aminooxyethyl)-1,4-diaminobutane (AOE-Put). The 3H- labeled derivatives of AP-APA and 
AOE-PU have also been synthesized.89 The aminooxy Spm analogues were synthesized 
with similar reactions using the orthogonal protective group strategy.92 The synthesis of the 
monoacetylated derivates of AOE-Put, AP-APA89 and AOSpm92 has also been described. 
Furthermore, oxa-analogue of Spm (1,12-diamino-4,9-diaza-5-oxadodecane, oxa-Spm) was 
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prepared using this same synthetic strategy.93 In addition, the synthesis of the oxa-analogue 
of Spd and bisoxaanalogue of Spm have been described.94 The pKa values for the aminooxy 
or –oxa polyamine analogues have not been fully characterized and only the pKa values of 
the aminooxy or –oxa groups are known (figure 7). 
 
Figure  7. The structures of the isosteric amino-oxy and –oxa analogues of natural polyamines and the pKa values of the aminooxy and 
–oxa group.52 
2.5.2 Biochemical features of the aminooxy analogues of putrescine  
APA, the isosteric analogue of Put, is a very effective competitive inhibitor of mammalian 
ODC (Ki 3.2nM); it irreversibly inhibits liver AdoMetDC and is also a competitive inhibitor 
of bovine brain SpdSy9 and it is not metabolized to longer analogues. Interestingly, APA 
did not show any inhibition of AdoMetDC or SpdSy from E. coli, although it could block 
ODC of bacteria with Ki of 1 nM.95 Furthermore, APA did not compete with natural 
polyamines for transport even in situations where the polyamines had been depleted.96 The 
bisaminooxy analogue of Put was not an inhibitor of ODC9 whereas the introduction of 
hydroxyl— or fluorine into the 2- position in the backbone of APA retained the ODC 
inhibitory efficacy (table 2)90. Disturbances of Golgi apparatus were observed, when BHK 
cells were treated with APA.97 In all of the studied cases, APA passively accumulated inside 
cells. However, in the case of L.donovani it proved possible to convert the compound into an 
actively transported inhibitor, γ-guanidinooxypropylamine (GAPA, pKa 6.71)98, which itself 
inhibited L.donovani ODC with a Ki value of 60 μM, while IC50 towards amastigotes was 
already 9.0 μM99. Moreover, GAPA, in contrast to APA was found to be effective even 
against sodium antimony gluconate-resistant forms of the parasite.100  
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Table 2. Inhibition of mammalian ODC by hydroxylamine-containing analogues of putrescine  
Compound Abbreviation. Source of ODC IC50, M Ref. 
 
APA 
Mouse liver 
Rat liver 
2 10-8 
1,5 10-8 
9 
90 
 
Bis-APA Mouse liver > 10-6 9 
 
2-OH-APA Rat liver 3,8 10-8 90 
 
R-2-OH-APA Rat liver 4,9 10-8 90 
 
S-2-OH-APA Rat liver 3,3 10-8 90 
 
2-F-APA Rat liver 1,4 10-8 90 
The table adapted from 101 
2.5.3 Biochemical features of the isosteric aminooxy analogues of Spd and Spm  
The Spd analogues AP-APA and AOE-Put are both moderate inhibitors of ODC and good 
inhibitors of AdoMetDC and SpmSy.7 The affinity of the analogues was dependent on the 
localization of the charge as AOE-Put had an order of magnitude higher affinity than Spd 
while the affinity of the AP-APA was an order of magnitude lower. Both of the Spd 
analogues have been postulated to be substrates of SSAT but no data has been presented to 
verify this hypothesis.89 Like the parent Spd, AOE-Put was not a substrate of APAO 
whereas the acetylated AOE-Put was shown to be a weak substrate (kcat 0.54 s-1).102 Both AP-
APA and AOE-Put, exhibited moderate inhibition of cell proliferation in a dose dependent 
manner.103 Both of the isosteric Spd analogues had different effects on the rat hippocampal 
NMDA receptor complex, AP-APA was found to be an antagonist whereas AOE-Put was a 
partial agonist.104   
The Spm analogue, AOSpm, did not show any inhibitory activity towards ODC or 
AdoMetDC, therefore differentiating it from the aminooxy analogues of Put or Spd.10 It was 
demonstrated to be a substrate of SSAT and to effectively compete for uptake with all three 
natural polyamines. Thus, it seems to be actively transported through polyamine transport 
system and it was postulated that AOSpm might be recognized similarly as Spm. 
Interestingly, AOSpm did not have any impact on polyamine levels or on the proliferation 
of Caco-2 cells10 or BHK cells while it was shown to moderately inhibit the growth of the 
rapidly proliferating L1210 cells8.  The aminooxa analogue of Spm, oxa-Spm, was designed 
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to act as an inhibitor of SMO93 but its biochemistry, as well as the biochemical properties of 
other oxa analogues of Spd and Spm94, is still unclear.  
Only AP-APA and AOSpm, where the two positive charges were separated with 
trimethylene moiety, were able to induce DNA aggregation when the interactions of the 
polyamine analogues AP-APA, AOE-Put and AOSpm with DNA were studied.105 
Furthermore, AOSpm was found to induce DNA condensation at physiological pH 
whereas the Spd analogues showed similar properties only at low pH values. AOSpm was 
also shown to protect DNA from oxidative damage and in that way was similar to Spm.10 
AP-APA was not an inhibitor of deoxyhypusine synthase, thus resembling to another 
charge deficient Spd isostere, 7,7-F2-Spd.73 
2.6 POLYAMINE ANALOGUES WITH ALTERED CARBON CHAIN LENGTH 
AND NUMBER OF AMINO GROUPS 
While the introduction of fluorine or the aminooxy group into the polyamine backbone 
decreases the charge of the molecules with minimal steric disturbances, the third family of 
charge deficient analogues changes display in the location and the number of the amino 
groups. When the length of the carbon chain between amino groups is shortened, then the 
total charge of the analogues is decreased and some of the pKa values of the molecules can 
be very low. Most of the biochemical studies with these kinds of analogues have 
concentrated on what features of polyamines are needed to support cell growth, polyamine 
transport and DNA condensation. Some, but not all, of the analogues belonging to this 
family are isosteric to the natural polyamines.  
2.6.1 The chemistry of the polyamine analogues with altered carbon chain lengths.  
There are various different synthetic strategies which can be exploited to form a C—N bond 
and this topic has been widely reviewed106, 107 The same synthetic methodology can be 
followed for the synthesis of the analogues with altered chain lengths as for the natural 
polyamines and their metabolites. The synthesis of the symmetrical analogues of the family 
is straightforward108, 109 whereas seven synthetic steps are needed with orthogonal 
protection for the synthesis of 1,12-diamino-3,6,9-triazadodecane110 (SpmTrien, 3-2-2-2) 
(scheme 6). Recently, a large scale synthesis for SpmTrien was devised starting from 
triethylenetetraamine (1,8-diamino-3,6-diazaoctane, Trien) with a simple Michael addition 
of acrylonitrile followed by a catalytic hydrogenation, but purification of the nitrile 
intermediate  was rather challenging (Paper I). The acetylated metabolites of SpmTrien 
(N1— and N12-mono-Acetyl SpmTrien) and Trien (N1-Ac-Trien (MAT) and N1,N8-Ac2-Trien 
(DAT)) have also been synthesized (Paper II).   
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 a(a) H2N(CH2)2NH(CH2)2OH; (b) CbzCl, (c) MsCl, Et3N; NaHCO3; (d) H2N(CH2)2NH2; (e) o-C6H4(OH)CHO/THF; (f) MeONH2; (g) H2/Pd, AcOH, 
MeOH  
Scheme 6. A) The synthesis of the polyamine analogue 3-2-3 using Michael Addition reaction followed by hydrogenation108; B) the 
synthesis of SpmTrien110 
The reduction of the carbon chain length between amino groups from three or four to two 
creates a significant increase in the electrostatic repulsion between the amino groups.13 The 
electrostatic repulsion between amino groups decreases when the chain is elongated to 
propylenic and it becomes irrelevant with butylenic or a longer carbon spacer. This 
phenomenon can be seen from the studies of the pKa values of diamines with different 
lengths of the aliphatic carbon chain between the amino groups.111 Compounds with only a 
methylenic spacer between the amino groups are unstable. Thus, there is a large decline in 
the pKa values of the polyamine analogues of this family, which contain the short ethylenic 
spacer between amino groups (table 3). All of the pKa values of the analogues from this 
family have been determined with potentiometric methods and only the protonation of the 
analogue SpmTrien was determined with NMR (Paper I). The protonation of SpmTrien is 
interesting as the protonation does not occur in the classical way and an amphoteric 
character of nitrogens is observed from the 15N shifts. Thus, the protons seem to drift 
between secondary amines of the molecule at the physiological pH, which is a unique 
feature of the polyamine analogue. It is important to note that the pKa values of other 
polyamine analogues have not been studied with 1H-15N coupled 2D NMR method, which 
revealed the drifting proton(s) of SpmTrien. 
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Table 3. The structures and the pKa values of the polyamine analogues with altered chain length. The net charge in pH 7.4 is 
calculated from the published pKa values using the Henderson-Hasselbach equation. 
Compound Abbr. 
pKa 
Net 
Charge* 
Ref 
1 2 3 4 5 
 
2-3 10.21 9.17 6.10   2.03 13 
 
2-3-2 10.08 9.26 6.88 5.45  2.23 13 
 
3-2-3 10.53 9.77 8.30 5.59  2.90 13 
 
Trien 9.74 9.07 6.59 3.27  1.97 13 
 
SpmTrien 10.3 9.5 8.5 6.3 3.3 2.99 112 
 
3-2-2-3 10.72 10.50 8.94 7.89 3.96 3.73 13 
 
2-2-2-2 9.70 9.14 8.05 4.70 2.92 2.80 13 
 
2.6.2 The biochemistry of the charge deficient polyamine analogues with altered chain 
length. 
Most of the members of this family have been studied for their ability to replace the 
functions of natural polyamines; restore growth after DFMO induced growth arrest of cells; 
the uptake competition and cell migration (table 4). Even though all of the analogues can 
mimic at least some functions of the natural polyamines109 and also interact with DNA in 
vitro72, 113, this group of analogues has not been systematically evaluated for their effects in 
the polyamine metabolizing pathway with the exception of the newest analogue in this 
family, SpmTrien, which is isosteric to Spm, as well as the molecule from which SpmTrien 
was derived, Trien, which is isosteric to Spd. The ability of the analogues to cause a B-to-Z 
transition in the DNA conformation correlated with their ability to overcome the DFMO 
induced growth arrest.113 Interestingly, Trien was found to restore cell growth after DFMO 
induced growth arrest in DU145 cells (Paper I) while it was ineffective in IEC-6 cells109. 
Furthermore, Trien and SpmTrien were both found to compete with [14C]-Put for transport 
but the competition with 14C-labelled Spd and Spm was weak, suggesting that they had low 
affinity toward polyamine transport (Paper II). Nevertheless, the concentration of SpmTrien 
was found to be as high inside cells as the concentration of natural polyamines, ponting to 
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another mechanism to account for the entry of the molecule into the cells. In addition, a 
copper chelating isosteric charge deficient analogue of norspermine, 1,11-diamino-3,6,9-
triazaundecane (2-2-2-2), has been synthesized but it has not been viewed as a polyamine 
even though it has been used in stem cell differentiation experiments and clearly affected 
CD34 and CD38 expression levels.114 2-2-2-2 has been undergoing phase I/II clinical trials 
for transplantation of umbilical cord blood derived hematopoietic stem cells grown ex vivo. 
115 
Table 4. The ability of the charge deficient analogues with the altered chain length to replace the functions of natural polyamines. 
Abbreviation Uptakea Cell growthb Cell migrationb Ref. 
2-3 No Yes Yes 109 
2-3-2 No Yes Yes 109 
3-2-3 No Yes Yes 109, 113 
Trien No 
No(IEC-6 Cells) 
Yes(DU145 cells) 
Yes 109, 112, 116 
SpmTrien No Yes ND. 112, 116 
3-2-2-3 ND. Yes ND. 113 
a Competition with [14C]Spd, bGrowth recovery after PA depletion with DFMO; ND. Not determined 
2.6.3 Trien and SpmTrien in the polyamine catabolizing pathway 
Both Trien and SpmTrien were found to be substrates of SSAT with Vmax values around 1.2 
(μmol/min)/mg of enzyme for both of the analogues and Km values of 144 and 106 μM, 
respectively (Paper II). In addition, Trien was a substrate of mouse SSAT in vivo, but also 
another enzyme, recombinant human thialysine acetyltransferase, was identified as being 
able to acetylate Trien in vitro (Paper III). While Trien or its acetylated metabolites were not 
substrates of either of the FAD-dependent polyamine oxidases, SMO and APAO, N12-Ac-
SpmTrien proved to be a good substrate of APAO, resulting Trien as the oxidation product. 
This provided additional information about the differences between substrate recognition 
of these polyamine oxidases. SMO seems to need adequate protonation of the central part 
of the substrate polyamines while APAO is not so demanding about the charge state of the 
substrate molecule(s), which is not surprising because SMO has narrower substrate 
specificity than APAO. It was found that SpmTrien downregulated ODC and AdoMetDC 
activity and also moderately induced SSAT activity while Trien did not evoke any changes 
in the enzyme activities (Papers I, II). 
2.6.4 Biochemical properties of the N,N´-di-ethylated charge deficient analogues with 
altered chain lengths  
The isosteric charge deficient analogue of di-ethyl-Spm, BE-SpmTrien, is the only 
diethylated isosteric charge deficient analogue of BE-Spm, which has been systematically 
tested with the polyamine catabolizing enzymes as well as in vitro (Paper II). Another di-
ethylated analogue from this family, BE-3-2-3 has also been tested for its ability to induce 
changes in the conformation of DNA and for its ability to substitute for some of the 
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functions of the natural polyamines.113 BE-3-2-3 could not overcome DFMO induced growth 
arrest. Interestingly, treatment of 9L cells with BE-3-2-3 caused a significant elevation in the 
Put and Spd concentrations over 3 days. In addition, BE-SpmTrien possessed no ability to 
overcome DFMO induced growth arrest and it did not have any biological activity towards 
regulatory enzymes of polyamine metabolism (Paper II). 
2.6.5 Charge deficient polyamine conjugates with altered chain length  
The natural polyamines and their analogues with reduced charges and chain lengths have 
been conjugated with different lipids to create novel agents for non-viral gene delivery.117, 118 
Polyamines can interact with DNA very efficiently and they can cause DNA condensation. 
Therefore they are very interesting molecules to be used in experiments attempting 
transfection in vitro and in vivo. The chemistry and biological properties of polyamine-
steroid conjugates have been reviewed by Blagbrough et al.119 Long polyamines with linear 
and branched polyethyleneimine (—NCH2CH2N—) chain have also been investigated in 
non-viral gene therapy systems.120 
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2.7 THE CHARGE DEFICIENT POLYAMINES BEARING A CYCLIC RING IN 
THEIR BACKBONE 
The last family of the charge deficient polyamine analogues has a more rigid structure in 
their backbone due to the replacement of the aliphatic carbon chain between amino groups 
with a cyclic ring. This family was synthesized to learn more about the features of the 
polyamine transport system76 as well as to investigate the regulation of the NMDA-
receptor62. The charge deficient analogues of this family have an aromatic pyridine ring at 
their carbon chain and have total charge of two at the physiological pH (table 5). The 
properties of the pyridine bearing polyamines were compared with polyamines bearing a 
non-aromatic piperidyl ring system in their backbone. While these analogues provided 
interesting insights into the role of charge in polyamine transport system as well as 
interactions of SSAT, ODC and AdoMetDC with their substrates, they have not 
subsequently been extensively utilized in the studies clarifying the biochemistry of either 
polyamines or the NMDA-receptor except for the longest pyridine containing analogue, 
which was a very efficient partial agonist of the NMDA-receptor with EC50 values in the nM 
range62. 
Table 5. The charge deficient polyamine analogues bearing cyclic ring at their backbone and their fully protonated counterparts. The 
net charge in pH 7.4 is calculated from the published pKa values62,76 using the Henderson-Hasselbach equation. 
Compound 
pKa Net 
charge 1 2 3 4 
 
11.18 10.67 8.88 7.17 2.97 
 
9.55 9.18 <2a <2a 1.98 
 
10.93 10.69 9.43 8.45 3.91 
 
9.23 7.64 4.43 3.77 1.62 
 
10.93 10.82 10.01 9.10 3.98 
 
9.81 8.85 5.69 4.93 1.98 
apKa value was approximated to be 2 in the calculations of the net charge  
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4 Aims of the study 
The correct localization of charges in the backbone of Spm, Spd and all of their analogues is 
one of the key descriptors determining the distinct biological effects of these molecules. 
Thus, one could predict that even small changes to the total charge and the distribution of 
the charges along the polyamine backbone would create compound with very interesting 
biochemical properties and which could help to clarify the complex biochemistry of 
polyamines and their analogues. The aims of this thesis were to examine the chemical and 
biochemical properties of SpmTrien, the latest charge deficient Spm analogue, and the 
corresponding Spd analogue, Trien. The more specific aims were:  
i) To determine the acid dissociation constants and the protonation of the novel 
charge deficient Spm analogue, SpmTrien (papers I and IV) 
ii) To examine whether SpmTrien, Trien and their acetylated analogues were 
substrates of polyamine the catabolizing enzymes (paper II)  
iii) To determine to what extent SpmTrien could mimic the natural polyamines 
(papers I and II) 
iv) To characterize the metabolism of SpmTrien and Trien in vitro and in vivo 
(papers II and III) 
v) To clarify the chemical features of the acetylated metabolites of SpmTrien and 
Trien (paper III) 
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5 General methods 
The general methods that were used in this thesis are briefly described in this chapter. The 
more detailed methodologies can be found in the papers cited after each general procedure. 
4.1 SYNTHETIC METHODS 
The synthesis of the novel polyamine analogues and their acetylated derivates relied on the 
classical strategy of using orthogonally protected precursors (Paper II). Typically, the 
required polyamine derivatives were prepared from commercially available starting 
materials by using Cbz-group protection followed by chain elongation with the required 
carbon chain moiety containing a suitable leaving group (e.g. mesylate). In the last step, the 
protecting groups were removed with catalytic hydrogenation and the target molecules 
were crystallized as HCl salts. This type of synthetic methodology provides high purity 
analogues and each intermediate can be readily purified with conventional 
chromatography. A large scale synthesis was also deviced for the synthesis of SpmTrien 
(Paper I). A simple Michael addition reaction of acrylonitrile with Trien was followed by 
purification on aluminium oxide. After catalytic hydrogenation, SpmTrien was crystallized 
as the HCl salt. Methanol and aqueous ammonia mixture proved to be best for complex 
purification of the nitrile intermediate when neutral alumina was used as the column 
material.   
4.2 NMR SPECTROSCOPY 
In the characterization of the synthetic products, 1H and 13C NMR spectra were measured 
on Bruker Avance 500 DRX (Germany) using tetramethylsilane (TMS) in CDCl3 or sodium 
3-(trimethylsilyl)-1-propanesulfonate (TSP) in D2O as the internal standards. Chemical 
shifts are given in ppm, and the letter "J" indicates normal 3JHH сouplings and all J values are 
given in Hz (Papers I, II, III). 2D NMR spectra were measured using standard pulse 
programs. A double-tube system to avoid mixing of H2O and D2O was used to reveal the 
protonation order of SpmTrien and for the follow up of the intramolecular acyl migration 
reaction (Papers I, III, IV). The sample preparation for each experiment is described in 
detail in the appropriate publication.   
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4.3 MASS SPECTROMETRY 
All mass spectra were obtained on an Applied Biosystems/MDS Sciex QSTAR XL 
spectrometer using the ESI technique. The operation and the spectral processing were 
performed on the manufacturer´s software. The high resolution mass spectra were recorded 
using direct infusion (Papers I, II). The intramolecular acetyl migration reaction products 
were separated using reversed phase chromatography and heptafluorobutyric acid as the 
ion pairing agent prior to mass spectrometric detection (Paper III).  
4.4 COMPUTATIONAL METHODS 
SCC-DFTB/MM MD simulations, QM calculations and Cluster expansion were used to 
obtain the necessary information about the charge tautomers of SpmTrien (Paper IV). 
4.5 RECOMBINANT PROTEIN METHODS 
The recombinant proteins were produced in E. Coli and purified with His-tag affinity 
chromatography (Papers II, III). Substrate and kinetic experiments with APAO and SMO 
were analysed with HPLC using post-column o-phthaldialdehyde-derivatization (Paper II). 
The inhibition experiments for both oxidizing enzymes were studied using Ampliflu red 
that was converted into a fluorescent compound (resorufin) by horseradish peroxidase 
when H2O2 was released in the enzyme oxidation reaction (Paper II).  
In the determination of the acetylating activity of the acetyltransferase enzymes, cation 
binding cellulose discs were used to separate the [14C]- acetylated products from the [14C] 
labeled acetyl-CoA substrate (Papers II, III).  
4.6 CELL CULTURE METHODS 
Typically, cellular experiments were performed with DU145 cells (Papers I, II). The samples 
for the polyamine measurements were taken and mixed 9:1 with 50 % sulphosalicylic acid 
containing 100 M diaminoheptane. The polyamine concentrations were quantified with 
HPLC using post-column o-phthaldialdehyde-derivatization. The supernatant fraction 
from the cell lysate was used for enzymatic assays of polyamine metabolic enzymes (Papers 
I and II: AdoMetDC, ODC, SSAT. Paper II; SMO and APAO). [14C]-labelled Put, Spd or Spm 
were used in the competitive uptake experiments and cycloheximide was used in the 
experiments where antizyme was depleted (Paper II). 
  
53 
 
4.7 IN VIVO METHODS 
The animal experiments on Trien metabolism were performed with three different mouse 
lines, SSAT overexpressing, SSAT knockout and syngenic mice (Paper III). The animal 
experiments were approved by the Animal Care and Use Committee at the Provincial 
Government of Southern Finland and carried out in accordance with the EU regulations 
(Paper III). 
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10 Summary 
The macroscopic pKa values of SpmTrien (3.3, 6.3, 8.5, 9.5 and 10.3), which were determined 
with potentiometric titration, are comparable to those of similar altough symmetric 
molecules (Paper I). Based on the 15N NMR—pH titration results, the protonation of 
SpmTrien occured first at both ends of the molecule. Interestingly, there was equilibrium in 
the protonation of the secondary amino groups of SpmTrien when the pH value was 
between 7 and 8. This caused a ‘‘wrong way’’ evolution in the 15N chemical shifts, which 
can be explained by a proton migration from the central N-III amino group to either NII or 
N-IV amino groups when the third proton had been introduced into the molecule. This 
phenomenom was further studied with two separate computational methods in order to 
obtain the accurate resolution of the microstates of each population of charges. The 
computational results showed that the equilibrium in the protonation of the secondary 
amino groups did not favor the protonation of the N-II amino group (Paper IV). This is not 
surprising because the electrostatic repulsion between charges at the backbone of SpmTrien 
should be smaller when either N-III or N-IV is first protonated. Furthermore, the 
protonation of SpmTrien was different from that in the previously known similar 
compounds with symmetry, providing some explanation for the unique biochemical 
properties of this compound. It has to be noted that the symmetrical analogues are still 
lacking a systematic biochemical characterization. The comparison of the computational 
methods showed that there was no difference between the computational method that was 
based on 15N NMR chemical shifts and the cluster expansion method, based solely on 
macroscopic pKa values. The cluster expansion method provided reliable results without 
the need for time consuming NMR measurements and computation time and thus it can be 
confidently used to calculate different microstate populations of polyamines and their 
analogues with accuracy. It is necessary to observe that the selection of the descriptors has 
to be made with care to the analogue of choice and only similar molecules can be used 
when being compared to previous data.  
Both of the isosteric charge deficient analogues studied in this thesis, Trien and SpmTrien, 
showed polyamine-like properties to some extent. Trien was able to restore cell growth 
after DFMO induced growth arrest in DU145 cells (PAPER I and II). Furthermore, Trien 
and SpmTrien both were found to compete with [14C]-Put for transport to some extent but 
the competition with 14C-labelled Spd and Spm was low, suggesting that they possessed 
low affinity for the polyamine transporter (PAPER II). However, the concentration of 
SpmTrien was found to be as high inside cells as the concentration of the natural 
polyamines, suggesting another mechanism for the entry of the molecule into the cell. Both 
Trien and SpmTrien were found to be substrates of SSAT. While Trien or its acetylated 
metabolites were not substrates of either SMO or APAO, N12-Ac-SpmTrien was a good 
substrate of APAO, resulting in the formation of Trien as the oxidation product (PAPER II). 
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This provided additional information about the differences between the substrate 
recognition properties of these polyamine oxidases. SMO seems to need adequate 
protonation of the central part of the substrate polyamine while APAO is not so fussy about 
the charge state of the substrate molecule(s). This is not surprising because SMO has 
narrower substrate specificity than APAO. SpmTrien downregulated ODC and AdoMetDC 
activity and also moderately induced SSAT activity while Trien did not evoke any changes 
in the enzyme activities. In addition, Trien was shown to be a substrate of mouse SSAT in 
vivo, but the enzyme was not the sole acetylator of the molecule and another enzyme, 
recombinant human thialysine acetyltransferase, was identified as being able to acetylate 
Trien in vitro (Paper III). As yet, the metabolism of SpmTrien has not studied in 
experimental animals and these experiments will need to be conducted to understand the 
complex metabolism of these polyamine analogues. Both of the recongnized metabolites of 
Trien, MAT and DAT, were observed to undergo intramolecular acetyl migration reaction 
in the acidified HPLC sample matrix (Paper III). This phenomenon may hamper also the 
determination of the metabolism of SpmTrien with the conventional HPLC method. Thus 
an LC-MS based method, relying on the use of deuterated molecules as internal standards, 
will need to be developed before one can clarify the in vivo metabolism of this Spm 
analogue.  
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11 Future prospects 
The isosteric charge deficient analogues of Spm and Spd, i.e. SpmTrien and Trien, have 
shown interesting properties both chemically and biochemically. The studies into the 
protonation of SpmTrien showed that microstate populations of different charges of 
SpmTrien can be calculated with sufficient accuracy without NMR data simply by using the 
cluster expansion method. Microstate populations of other analogues can also be 
determined with the same methodology, providing an opportunity to extract more 
chemical knowledge from pKa values to explain the differences in the biochemical 
properties of different novel analogues. Our goal in the near future is to determine the pKa 
values and protonation of differently backbone substituted Spd and Spm analogues in 
order to elucidate whether the changes in the conformation of these analogues give rise to 
internal factors which alter the pKa values in addition to the obvious steric changes.  
Trien has been shown to be an interesting compound with many different potential drug 
uses. Based on our current knowledge about the properties of this compound it seems to 
have also other mechanisms of action in addition to known Cu2+ chelation. The metabolism 
of this compound will be further studied to provide novel insights into the different 
signaling routes that may be influenced after the administration of Trien. Furthermore, the 
uptake of SpmTrien is higher than that of Trien and the possible drug use of this compound 
will hopefully be conducted in the future. Both of the compounds share a similar backbone 
with the norspermine isostere, 2-2-2-2, which would also be an interesting compound for 
examination in a systematic characterization of the polyamine metabolizing pathway. 
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